Skip to main content

Table 4 Studies measuring circulating celecoxib levels

From: Celecoxib concentration predicts decrease in prostaglandin E2concentrations in nipple aspirate fluid from high risk women

Population

Subjects

Weeks On Drug

Dose (mg)1

Last Dose (hrs)2

Source

Celecoxib concentration (ng/mL)

Healthy Adults [18]

8

2

200 b.i.d.

up to 25

serum

437

Healthy Adults [18]

35

2

40 q.d.

13

plasma

568

Healthy Adults [18]

24

2

200 b.i.d.

up to 24

plasma

500

Healthy Adults [20]

35

6

400 q.d.

13

plasma

601

Elderly Adults [21]

8

1

200 b.i.d.

2

plasma

755

Pediatric cancer patients [22]

9

250 mg/kg

b.i.d.

6

plasma

668

Adult cancer patients [23]

4

week3

400 b.i.d.

6–8

plasma

1087

  1. 1: b.i.d.: twice daily; q.d.: once daily
  2. 2: Unless otherwise stated, average time from last dose celecoxib to blood draw
  3. 3: The text did not define how many weeks the subjects took the medication